PROCTER & GAMBLE HEALTH | SAKAR HEALTHCARE | PROCTER & GAMBLE HEALTH/ SAKAR HEALTHCARE |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 34.6 | 62.0 | 55.8% | View Chart |
P/BV | x | 10.6 | 4.5 | 236.6% | View Chart |
Dividend Yield | % | 2.0 | 0.0 | - |
PROCTER & GAMBLE HEALTH SAKAR HEALTHCARE |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
PROCTER & GAMBLE HEALTH Jun-23 |
SAKAR HEALTHCARE Mar-23 |
PROCTER & GAMBLE HEALTH/ SAKAR HEALTHCARE |
5-Yr Chart Click to enlarge
|
||
High | Rs | 5,366 | 295 | 1,818.8% | |
Low | Rs | 3,883 | 112 | 3,473.2% | |
Sales per share (Unadj.) | Rs | 740.7 | 70.0 | 1,057.6% | |
Earnings per share (Unadj.) | Rs | 138.2 | 6.7 | 2,062.9% | |
Cash flow per share (Unadj.) | Rs | 155.2 | 14.6 | 1,064.8% | |
Dividends per share (Unadj.) | Rs | 95.00 | 0 | - | |
Avg Dividend yield | % | 2.1 | 0 | - | |
Book value per share (Unadj.) | Rs | 447.6 | 91.0 | 491.7% | |
Shares outstanding (eoy) | m | 16.60 | 19.04 | 87.2% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 6.2 | 2.9 | 215.0% | |
Avg P/E ratio | x | 33.5 | 30.4 | 110.2% | |
P/CF ratio (eoy) | x | 29.8 | 14.0 | 213.5% | |
Price / Book Value ratio | x | 10.3 | 2.2 | 462.4% | |
Dividend payout | % | 68.7 | 0 | - | |
Avg Mkt Cap | Rs m | 76,761 | 3,873 | 1,982.1% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2,062 | 158 | 1,304.2% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 12,296 | 1,334 | 922.0% | |
Other income | Rs m | 184 | 47 | 393.4% | |
Total revenues | Rs m | 12,480 | 1,380 | 904.1% | |
Gross profit | Rs m | 3,247 | 333 | 976.0% | |
Depreciation | Rs m | 281 | 150 | 187.5% | |
Interest | Rs m | 8 | 60 | 12.9% | |
Profit before tax | Rs m | 3,142 | 170 | 1,849.2% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 847 | 42 | 2,001.7% | |
Profit after tax | Rs m | 2,295 | 128 | 1,798.5% | |
Gross profit margin | % | 26.4 | 24.9 | 105.9% | |
Effective tax rate | % | 27.0 | 24.9 | 108.3% | |
Net profit margin | % | 18.7 | 9.6 | 195.1% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 11,713 | 559 | 2,094.7% | |
Current liabilities | Rs m | 6,791 | 545 | 1,246.2% | |
Net working cap to sales | % | 40.0 | 1.1 | 3,749.0% | |
Current ratio | x | 1.7 | 1.0 | 168.1% | |
Inventory Days | Days | 263 | 29 | 892.4% | |
Debtors Days | Days | 343 | 604 | 56.8% | |
Net fixed assets | Rs m | 10,617 | 2,804 | 378.6% | |
Share capital | Rs m | 166 | 190 | 87.2% | |
"Free" reserves | Rs m | 7,265 | 1,543 | 470.8% | |
Net worth | Rs m | 7,431 | 1,733 | 428.6% | |
Long term debt | Rs m | 0 | 982 | 0.0% | |
Total assets | Rs m | 22,330 | 3,363 | 663.9% | |
Interest coverage | x | 409.1 | 3.8 | 10,626.4% | |
Debt to equity ratio | x | 0 | 0.6 | 0.0% | |
Sales to assets ratio | x | 0.6 | 0.4 | 138.9% | |
Return on assets | % | 10.3 | 5.6 | 185.2% | |
Return on equity | % | 30.9 | 7.4 | 419.6% | |
Return on capital | % | 42.4 | 8.5 | 501.5% | |
Exports to sales | % | 0 | 78.4 | 0.0% | |
Imports to sales | % | 13.1 | 0 | - | |
Exports (fob) | Rs m | NA | 1,045 | 0.0% | |
Imports (cif) | Rs m | 1,605 | NA | - | |
Fx inflow | Rs m | 1,465 | 1,045 | 140.2% | |
Fx outflow | Rs m | 1,605 | 355 | 451.8% | |
Net fx | Rs m | -140 | 690 | -20.3% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,360 | 333 | 707.8% | |
From Investments | Rs m | -215 | -744 | 28.9% | |
From Financial Activity | Rs m | -985 | 411 | -239.6% | |
Net Cashflow | Rs m | 1,160 | 1 | 181,296.9% |
Indian Promoters | % | 0.0 | 53.2 | - | |
Foreign collaborators | % | 51.8 | 0.0 | - | |
Indian inst/Mut Fund | % | 20.0 | 24.1 | 82.7% | |
FIIs | % | 6.2 | 13.5 | 46.2% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 48.2 | 46.9 | 102.8% | |
Shareholders | 56,778 | 7,386 | 768.7% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare PROCTER & GAMBLE HEALTH With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Procter & Gamble Health | SAKAR HEALTHCARE | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.43% | 0.28% | 0.45% |
1-Month | -1.15% | -3.61% | 2.55% |
1-Year | 0.73% | 65.98% | 56.14% |
3-Year CAGR | -8.76% | 46.39% | 15.22% |
5-Year CAGR | 4.97% | 40.86% | 19.63% |
* Compound Annual Growth Rate
Here are more details on the Procter & Gamble Health share price and the SAKAR HEALTHCARE share price.
Moving on to shareholding structures...
The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of SAKAR HEALTHCARE the stake stands at 53.2%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of SAKAR HEALTHCARE .
Finally, a word on dividends...
In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.
SAKAR HEALTHCARE paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of SAKAR HEALTHCARE .
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.